{
    "Trade/Device Name(s)": [
        "Randox Methamphetamine Assay",
        "Randox MultiDrug Calibrator",
        "Randox MultiDrug Controls Level 1 & 2"
    ],
    "Submitter Information": "Randox Laboratories, Ltd.",
    "510(k) Number": "K092266",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LAF",
        "DKB",
        "DIF"
    ],
    "Summary Letter Date": "April 20, 2011",
    "Summary Letter Received Date": "May 05, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3619"
    ],
    "Regulation Name(s)": [
        "Methamphetamine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Methamphetamine",
        "Oxazepam",
        "Methadone"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Daytona",
        "RX Daytona",
        "Imola"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay"
    ],
    "Methodologies": [
        "Qualitative testing",
        "Semi-quantitative testing"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Randox Methamphetamine Assay, MultiDrug Calibrator, and Controls for detection of methamphetamine, oxazepam, and methadone in human urine",
    "Indications for Use Summary": "Intended for qualitative and semi-quantitative detection of methamphetamine in human urine to aid in diagnosis and treatment of methamphetamine use or overdose; calibrator and controls for use in calibration and quality control of methamphetamine, benzodiazepines, and methadone assays",
    "fda_folder": "Toxicology"
}